Stocks Screener

Specify Company / Ticker to Get the Summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Certara Inc

CERT
Current price
14.15 USD +0.62 USD (+4.58%)
Last closed 9.37 USD
ISIN US15687V1098
Sector Healthcare
Industry Health Information Services
Exchange NASDAQ
Capitalization 2 284 885 248 USD
Yield for 12 month -12.44 %
1Y
3Y
5Y
10Y
15Y
CERT
21.11.2021 - 28.11.2021

Certara, Inc., together with its subsidiaries, provides technology-enabled services and software products for biosimulation in drug discovery, preclinical and clinical research, regulatory submissions, and market access in the United States and internationally. It offers solutions for model-informed drug development, as well as biosimulation solutions to predict pharmacokinetics and pharmacodynamics; Simcyp simulator, a mechanistic biosimulation platform for physiologically based pharmacokinetic simulation; Simcyp Discovery for scientists working on pre-investigational new drug and translational stages; Simcyp Biopharmaceutics for formulation scientists; and Simcyp Secondary Intelligence that integrates toxicology with quantitative analysis of large networks of molecular and functional biological changes. The company also provides Phoenix WinNonlin, a platform for non-compartmental analysis; Phoenix Hosted, which offers a secured and validated Certara Amazon Web Services workspace; Phoenix NLME, a population modeling and simulation software; and Pirana Modeling Workbench, which provides modelers with a structure to facilitate the iterative processes. In addition, it offers Chemaxon JChem engines, a chemical search engine; Chemaxon Compound Registration, which supports a streamlined lead optimization process workflow; Chemaxon Design Hub, a design and tracking platform for drug discovery teams and their external collaborators; Certara D360 software, a scientific informatics system for small molecule and biologics discovery research; and Chemaxon Marvin, a chemical drawing tool. Further, the company provides pinnacle 21, a cloud-based platform for clinical data automation, standardization, and validation; Pinnacle 21 Data Exchange to define data standards and specifications; Metadata Repository that enables study design using controlled and standardized data; CoAuthor software, which creates and assembles regulatory submissions and medical publications; and GlobalSubmit, a submissions management software. Certara I Address: 4 Radnor Corporate Center, Radnor, PA, United States, 19087

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

15.11 USD

P/E ratio

Dividend Yield

Current Year

+385 148 000 USD

Last Year

+354 337 000 USD

Current Quarter

+100 361 000 USD

Last Quarter

+94 820 000 USD

Current Year

+230 632 000 USD

Last Year

+213 315 000 USD

Current Quarter

+62 098 000 USD

Last Quarter

+57 631 000 USD

Key Figures CERT

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA 86 997 000 USD
Operating Margin TTM 14.40 %
Price to Earnings
Return On Assets TTM 0.75 %
PEG Ratio
Return On Equity TTM -1.15 %
Wall Street Target Price 15.11 USD
Revenue TTM 385 148 000 USD
Book Value 6.58 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY 14.00 %
Dividend Yield
Gross Profit TTM 230 632 000 USD
Earnings per share -0.080 USD
Diluted Eps TTM -0.080 USD
Most Recent Quarter IV 2024
Quarterly Earnings Growth YOY -14.10 %
Profit Margin -3.13 %

Dividend Analytics CERT

Max Ratio

>10 - expected double digit dividend yield on cost over 10Y >5 - expected 5-9 dividend yield on cost over 10Y <5 - expected <5 dividend yield on cost over 10Y MaxRatio is an estimated 10Y dividend yield on cost calculated by combining the current dividend yield with the 5-year & 10-year average dividend growth rate, projected over the next 10 years discounted based on current Financial Score. It provides a projected outlook on future dividend returns.

5Y Dividend Growth

Consecutive Years

5Y Average Payout Ratio

Dividend History CERT

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Ex Dividend Date
Dividend CAGR 3Y
Dividend CAGR 5Y
Dividend CAGR 10Y
Consecutive Years
Consistent Years
Continuous Dividends
Forward Annual Dividend Yield
Forward Annual Dividend – USD
Last Split Factor
Payout Ratio
Last Split Date

Stock Valuation CERT

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE 31.25
Enterprise Value Revenue 6.28
Price Sales TTM 5.93
Enterprise Value EBITDA 33.41
Price Book MRQ 2.16

Financials CERT

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators CERT

For 52 weeks

8.64 USD 17.94 USD
50 Day MA 11.78 USD
Shares Short Prior Month 5 913 263
200 Day MA 12.01 USD
Short Ratio 4.62
Shares Short 6 177 739
Short Percent 5.07 %